Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 20, 2022

Elevance Health (NYSE: ELV) will release second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

888-947-9963 (Domestic)

866-430-8797 (Domestic Replay)

312-470-0178 (International)

203-369-0943 (International Replay)

The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on July 20, 2022 until the end of the day on August 20, 2022. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. A webcast replay will be available following the call.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve more than 118 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  214.48
+1.44 (0.68%)
AAPL  258.10
+5.81 (2.30%)
AMD  236.25
+3.17 (1.36%)
BAC  51.46
+0.18 (0.35%)
GOOG  256.27
+2.48 (0.98%)
META  721.95
+5.04 (0.70%)
MSFT  514.50
+0.92 (0.18%)
NVDA  182.57
-0.65 (-0.35%)
ORCL  283.23
-8.08 (-2.77%)
TSLA  445.27
+5.96 (1.36%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.